Cargando…

Prepositioning antibiotics for anthrax /

"If terrorists released Bacillus anthracis over a large city, hundreds of thousands of people could be at risk of the deadly disease anthrax-caused by the B. anthracis spores-unless they had rapid access to antibiotic medical countermeasures (MCM). Although plans for rapidly delivering MCM to a...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Institute of Medicine (U.S.). Committee on Prepositioned Medical Countermeasures for the Public
Otros Autores: Stroud, Clare
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, 2012.
Colección:Online access: NCBI NCBI Bookshelf.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ia 4500
001 EBSCO_ocn775688619
003 OCoLC
005 20231017213018.0
006 m o d
007 cr |||||||||||
008 120209s2012 dcuab obt 001 0 eng d
010 |a  2011277666 
040 |a VVK  |b eng  |e pn  |c VVK  |d MMU  |d OCLCQ  |d N$T  |d IDEBK  |d YDXCP  |d UCNAP  |d E7B  |d CDX  |d ORU  |d GPM  |d OCLCQ  |d NLGGC  |d OCLCO  |d OCLCQ  |d OCLCO  |d EBLCP  |d DEBSZ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d D6H  |d OCLCO  |d AZK  |d AGLDB  |d VT2  |d MOR  |d PIFAG  |d ZCU  |d OCLCQ  |d MERUC  |d OCLCQ  |d MERER  |d OCLCA  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d BUF  |d CUY  |d OCLCQ  |d OCLCF  |d STF  |d WRM  |d VNS  |d OCLCQ  |d VTS  |d NRAMU  |d EZ9  |d OCLCQ  |d ICG  |d OCLCO  |d REC  |d AU@  |d OCLCO  |d OCLCQ  |d OCLCO  |d WYU  |d LVT  |d OCLCQ  |d DKC  |d OCLCO  |d OCLCQ  |d M8D  |d OCLCO  |d UX1  |d HS0  |d UWK  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCA  |d UKCRE  |d AJS  |d KIJ  |d OCLCO  |d OCLCQ  |d SFB  |d OCLCO  |d UKAHL  |d VHC  |d OCLCO  |d OCLCQ  |d OCL 
016 7 |a 101580803  |2 DNLM 
016 7 |a 016046986  |2 Uk 
019 |a 785337616  |a 785388263  |a 794491581  |a 817067864  |a 824114284  |a 923289134  |a 961499532  |a 962651306  |a 971083420  |a 988408941  |a 988476873  |a 991967272  |a 1037934366  |a 1038656266  |a 1038674086  |a 1045519661  |a 1047574109  |a 1055311884  |a 1065672173  |a 1081212725  |a 1109107869  |a 1110225013  |a 1153551029  |a 1156366076  |a 1162193500  |a 1204394016  |a 1227641012  |a 1228620655  |a 1229792841  |a 1241900226  |a 1249251656  |a 1290034286  |a 1300526051  |a 1303298647  |a 1303456851 
020 |a 9780309218092  |q (electronic bk.) 
020 |a 0309218098  |q (electronic bk.) 
020 |a 1280123206 
020 |a 9781280123207 
020 |a 9786613527066 
020 |a 6613527068 
020 |z 9780309218085 
020 |z 030921808X 
029 1 |a AU@  |b 000049145790 
029 1 |a AU@  |b 000051338024 
029 1 |a DEBBG  |b BV042795618 
029 1 |a DEBBG  |b BV044109385 
029 1 |a DEBSZ  |b 421432438 
029 1 |a DEBSZ  |b 452579376 
029 1 |a GBVCP  |b 80388835X 
029 1 |a NZ1  |b 15024135 
029 1 |a AU@  |b 000060015042 
035 |a (OCoLC)775688619  |z (OCoLC)785337616  |z (OCoLC)785388263  |z (OCoLC)794491581  |z (OCoLC)817067864  |z (OCoLC)824114284  |z (OCoLC)923289134  |z (OCoLC)961499532  |z (OCoLC)962651306  |z (OCoLC)971083420  |z (OCoLC)988408941  |z (OCoLC)988476873  |z (OCoLC)991967272  |z (OCoLC)1037934366  |z (OCoLC)1038656266  |z (OCoLC)1038674086  |z (OCoLC)1045519661  |z (OCoLC)1047574109  |z (OCoLC)1055311884  |z (OCoLC)1065672173  |z (OCoLC)1081212725  |z (OCoLC)1109107869  |z (OCoLC)1110225013  |z (OCoLC)1153551029  |z (OCoLC)1156366076  |z (OCoLC)1162193500  |z (OCoLC)1204394016  |z (OCoLC)1227641012  |z (OCoLC)1228620655  |z (OCoLC)1229792841  |z (OCoLC)1241900226  |z (OCoLC)1249251656  |z (OCoLC)1290034286  |z (OCoLC)1300526051  |z (OCoLC)1303298647  |z (OCoLC)1303456851 
043 |a n-us--- 
050 4 |a RA644.A6  |b I577 2012eb 
060 4 |a 2012 C-274 
060 4 |a WC 305 
072 7 |a HEA  |x 039040  |2 bisacsh 
072 7 |a MED  |x 022090  |2 bisacsh 
082 0 4 |a 616.95/6  |2 23 
049 |a UAMI 
245 0 0 |a Prepositioning antibiotics for anthrax /  |c Committee on Prepositioned Medical Countermeasures for the Public, Board on Health Sciences Policy ; Clare Stroud [and others] ; Institute of Medicine of the National Academies. 
260 |a Washington, D.C. :  |b National Academies Press,  |c 2012. 
300 |a 1 online resource (xiv, 343 pages) :  |b illustrations (some color), maps 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
380 |a Technical report 
520 |a "If terrorists released Bacillus anthracis over a large city, hundreds of thousands of people could be at risk of the deadly disease anthrax-caused by the B. anthracis spores-unless they had rapid access to antibiotic medical countermeasures (MCM). Although plans for rapidly delivering MCM to a large number of people following an anthrax attack have been greatly enhanced during the last decade, many public health authorities and policy experts fear that the nation's current systems and plans are insufficient to respond to the most challenging scenarios, such as a very large-scale anthrax attack. The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response commissioned the Institute of Medicine to examine the potential uses, benefits, and disadvantages of strategies for repositioning antibiotics. This involves storing antibiotics close to or in the possession of the people who would need rapid access to them should an attack occur. Prepositioning Antibiotics for Anthrax reviews the scientific evidence on the time window in which antibiotics successfully prevent anthrax and the implications for decision making about prepositioning, describes potential prepositioning strategies, and develops a framework to assist state, local, and tribal public health authorities in determining whether prepositioning strategies would be beneficial for their communities. However, based on an analysis of the likely health benefits, health risks, and relative costs of the different prepositioning strategies, the book also develops findings and recommendations to provide jurisdictions with some practical insights as to the circumstances in which different prepositioning strategies may be beneficial. Finally, the book identifies federal- and national-level actions that would facilitate the evaluation and development of prepositioning strategies. Recognizing that communities across the nation have differing needs and capabilities, the findings presented in this report are intended to assist public health officials in considering the benefits, costs, and trade-offs involved in developing alternative prepositioning strategies appropriate to their particular communities"--Publisher's description 
504 |a Includes bibliographical references and index. 
505 0 |a Introduction -- Antibiotics for anthrax postexposure prophylaxis -- Current dispensing strategies for medical countermasures for anthrax -- Prepositioning strategies -- A decision-aiding framework -- Recommended actions for moving forward. 
536 |a Supported by contract no. HHSO100201000003A between the National Academy of Sciences and the Dept. of Health and Human Services. 
588 0 |a Online resource; title from resource home page (National Academies Press, viewed March 19, 2012). 
546 |a English. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Anthrax  |z United States  |x Prevention. 
650 0 |a Biological warfare  |z United States  |x Safety measures  |x Evaluation. 
650 0 |a Bioterrorism  |z United States  |x Prevention  |x Evaluation. 
650 0 |a Bioterrorism  |z United States. 
650 0 |a Emergency management. 
650 0 |a Public health. 
650 2 |a Anthrax  |x prevention & control 
650 2 |a Anti-Bacterial Agents  |x supply & distribution 
650 2 |a Bioterrorism  |x prevention & control 
650 2 |a Disaster Planning 
650 2 |a Post-Exposure Prophylaxis  |x organization & administration 
650 2 |a Time Factors 
650 2 |a Anthrax  |x drug therapy 
651 2 |a United States 
650 2 |a Public Health 
650 6 |a Santé publique. 
650 6 |a Biosécurité. 
650 6 |a Guerre biologique  |z États-Unis  |x Sécurité  |x Mesures  |x Évaluation. 
650 6 |a Bioterrorisme  |z États-Unis. 
650 6 |a Gestion des situations d'urgence. 
650 7 |a public health.  |2 aat 
650 7 |a disaster planning.  |2 aat 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Contagious.  |2 bisacsh 
650 7 |a MEDICAL  |x Infectious Diseases.  |2 bisacsh 
650 7 |a Public health  |2 fast  |0 (OCoLC)fst01082238 
650 7 |a Emergency management  |2 fast  |0 (OCoLC)fst00908500 
650 7 |a Anthrax  |x Prevention.  |2 fast  |0 (OCoLC)fst00810165 
650 7 |a Bioterrorism.  |2 fast  |0 (OCoLC)fst00832824 
651 7 |a United States.  |2 fast  |0 (OCoLC)fst01204155 
700 1 |a Stroud, Clare. 
710 2 |a Institute of Medicine (U.S.).  |b Committee on Prepositioned Medical Countermeasures for the Public. 
776 0 8 |i Print version:  |t Prepositioning antibiotics for anthrax.  |d Washington, D.C. : National Academies Press, ©2012  |z 030921808X  |w (OCoLC)756166180 
830 0 |a Online access: NCBI NCBI Bookshelf. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=444947  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36559652 
938 |a Coutts Information Services  |b COUT  |n 21789442 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3378955 
938 |a ebrary  |b EBRY  |n ebr10554801 
938 |a EBSCOhost  |b EBSC  |n 444947 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 352706 
938 |a YBP Library Services  |b YANK  |n 7608229 
994 |a 92  |b IZTAP